Post by i-Pharm Consulting

CRO Parexel has acquired Vitrana, and it's an interesting move. Vitrana brings an AI-powered, end-to-end pharmacovigilance technology platform into Parexel's ecosystem, giving them a single partner model for both PV technology and services. The platform is system-agnostic, integrates with any safety database, and uses intelligent automation to improve accuracy, compliance, and cycle times. The development forms part of Parexel’s investment in AI-enabled solutions across clinical development, including regulatory submissions, trial execution, and patient safety. In a space where regulatory complexity and data volumes are only growing, this is exactly the kind of investment that positions a CRO for the long term.   One to watch 👀   #LifeSciences #Pharma #Pharmacovigilance #AI #CRO